ArticleOncoimmunology

S100A4 blockage alleviates agonistic anti-CD137 antibody-induced liver pathology without disruption of antitumor immunity.

Jinhua Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.